Horizon 2020: Clinical research on regenerative medicine (1)

The European Commission is inviting proposals on regenerative medicine therapies which are ready for clinical (in-patient) research. Preference will be given to proposals which have or are closest to having approvals in place for clinical work to start. Since the objective is to test new regenerative therapies, proposals may address any disease or condition but a justification for the choice must be provided. Clinical work should represent a central part of the project.

The deadline for applications is 24 February 2015. For further information, please visit the Horizon 2020 website.